Skip to content
DGX Quest Diagnostics Inc NYSE
132.78 USD 1.31% +1.72
OPEN 131.48
PREV CLOSE 131.06
DAY RANGE 133.06 - 131.22
VOLUME 120.8K
AVG. VOLUME 775.5K
52 WEEK RANGE 148.62 - 119.59
Interactive Brokers Logotype

Buy DGX stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 14.4B
Enterprise value 19.2B
Trailing pe 17.373833
Forward pe 13.828906
Peg ratio 13.828906
Price to sales ttm 1.5571015
Price to book mrq 2.2902148
Enterprise to revenue 2.074
Enterprise to ebitda 10.823

Financials

Fiscal year ends 2023-12-31
Most recent quarter 2023-12-31
Profit margin 0.0923
Operating margin 0.12937
Return on assets ttm 0.062080003
Return on equity ttm 0.14616
Income statement
Revenue ttm 9.3B
Revenue per share ttm 82.607
Quarterly revenue growth -0.019
Gross profit ttm 3.1B
Ebitda 1.7B
Net income to common ttm 850M
Diluted eps ttm 7.49
Quarterly earnings growth yoy 0.901
Balance sheet
Total cash mrq 686M
Total cash per share mrq 6.197
Total debt mrq 5.5B
Total debt to equity mrq 85.665
Current ratio mrq 1.307
Book value per share mrq 56.82
Cash flow
Operating cash flow ttm 1.3B
Levered free cash flow ttm 662.9M

Stock statistics

Shares outstanding 110.7M
Float shares 109.6M
Avg 10 volume 808.3K
Avg 90 volume 0.9M
Shares short 2.8M
Short ratio 2.37
Short percent of shares outstanding 0.0327
Percent held by insiders 0.00861
Percent held by institutions 0.92032

Stock price summary

Fifty two week low 119.59
Fifty two week high 148.62
Fifty two week change -4.903
Beta 0.895
Day 50 ma 127.908
Day 200 ma 132.05215

Dividends and splits

Forward annual dividend rate 2.84
Forward annual dividend yield 0.021391985537813
Trailing annual dividend rate 2.84
Trailing annual dividend yield 0.021391985537813
5 year average dividend yield 1.91
Payout ratio 0.3725
Dividend date 2024-04-22
Ex dividend date 2024-04-05
Last split factor 2-for-1 split
Last split date 2005-06-21

Quest Diagnostics (DGX) company profile

Quest Diagnostics (NYSE: DGX) is an independent provider of diagnostic testing, information, and services. The company engages in clinical testing, anatomic pathology, esoteric testing, and substance abuse testing. It operates through the segments of Diagnostic Information Services and Diagnostic Solutions.